BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
LEP
,
calcium channel activity
,
Ischemia
,
Stem cell
,
Human chorionic gonadotropin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
et%202
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for et%202
Explore Curated Studies Results
Literature
Most Relevant Literature
CYLD induces high oxidative stress and DNA damage through class I HDACs to promote radiosensitivity …
Whole-transcriptome defines novel glucose metabolic subtypes in colorectal cancer.
Structural characterization and hepatoprotective activity of exopolysaccharide from Bacillus velezen…
Integrated physiological, biochemical, and transcriptomic analysis of thallium toxicity in zebrafish…
Expression Patterns of Nrf2 and Keap1 in Ovarian Cancer Cells and their Prognostic Role in Disease R…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Phase 2 Safety and Efficacy Study of INCB050465 in Subjects With Relapsed or Refractory Diffuse La…
A Study to Evaluate Long Term Safety and Efficacy of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151…
Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)
Influence of Naproxen on Heterotropic Bone Formation Following Hip Arthroscopy
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ